Literature DB >> 1607399

Subcutaneous administration of methotrexate.

H S Zackheim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1607399     DOI： 10.1016/s0190-9622(08)80342-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Preference, satisfaction and usability of subcutaneously administered methotrexate for rheumatoid arthritis or psoriatic arthritis: results of a postmarketing surveillance study with a high-concentration formulation.

Authors:  Frank Striesow; Andreas Brandt
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

2.  Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis.

Authors:  Ulf Müller-Ladner; Karin Rockwitz; Jan Brandt-Jürgens; Roland Haux; Peter Kästner; Jürgen Braun; Winfried Demary; Cécile Guimbal-Schmolck; Uwe Pichlmeier; Andreas Brandt
Journal:  Open Rheumatol J       Date:  2010-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.